Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Akili Interactive

Akili Interactive
2011 FOUNDED
PRIVATE STATUS
91-100 EMPLOYEES
Series C LATEST DEAL TYPE
$68M LATEST DEAL AMOUNT
15 INVESTORS
Description

Developer of digital treatments for cognitve dysfunction with direct therapeutic activity. The company is developing a broad pipeline of programs built on its platform to treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and psychiatry, via an action video game, including attention-deficit hyperactivity/ disorder (ADHD), major depressive disorder (MDD), autism spectrum disorder (ASD) and various inflammatory diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
  • 125 Broad Street
  • 4th Floor
  • Boston, MA 02110
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Akili Interactive’s full profile, request a free trial.

Akili Interactive Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series C) 08-Aug-2018 $68M 00000 00000 Completed Clinical Trials - General
2. Early Stage VC (Series B) 20-Jul-2016 000.00 0000 00000 Completed Startup
1. Early Stage VC (Series A) 19-Feb-2012 $8.5M $8.5M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Akili Interactive Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A2 4,427,072 $0.000100 $2 $2 1x $2 14.6%
Series A1 4,000,000 $0.000100 $1 $1 1x $1 13.19%
To view this company’s complete Cap Table, request access »

Akili Interactive Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Click Therapeutics Venture Capital-Backed New York, NY 00 000.00 00000000000 000.00
0000 0000 Venture Capital-Backed New York, NY 0000
0000000000000 Venture Capital-Backed Boston, MA 00 000.00 0000000000 0 000.00
00000 000000 Corporate Backed or Acquired Washington, DC 0000 000000000000
00000 000000 Venture Capital-Backed San Francisco, CA 000 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Akili Interactive Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Amgen Ventures Corporate Venture Capital Minority 000 0000 000000 0
Baillie Gifford Asset Manager Minority 000 0000 000000 0
Brooklands Capital Strategies Venture Capital Minority 000 0000 000000 0
CLSA PE-Backed Company Minority 000 0000 000000 0
DG Incubation Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

Akili Interactive Executive Team (16)

Name Title Board
Seat
Contact
Info
Eddie Martucci Ph.D Co-Founder, Chief Executive Officer and Board Member
Santosh Shanbhag Chief Financial Officer
Matthew Omernick Co-Founder & Chief Creative Officer
LeRoux Jooste Chief Commercial Officer
Jacqueline Studer Senior Vice President & General Counsel

3 Former Executives

You’re viewing 5 of 16 executives. Get the full list »

Akili Interactive Board Members (11)

Name Representing Role Since Contact
Info
Alejandro Sanchez Canepa Healthcare Board Observer 000 0000
Bharatt Chowira Akili Interactive Board Member 000 0000
Edward Kliphuis Merck Ventures Board Observer 000 0000
Eric Elenko Ph.D PureTech Health Board Member 000 0000
Hu Hongjie Temasek Holdings Board Member 000 0000

2 Former Board Members

You’re viewing 5 of 11 board members. Get the full list »